Travere Therapeutics, Inc.
TVTX
60 insider filings · Latest: Sep 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Mar 18 8:05 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 10,000 | $28.09 | $280.9K | 105,211(D) | View → |
| Mar 16, 2026 | Mar 16 8:20 PM | ELIZABETH REED | Proposed Sale | 10,000 | $28.09 | $280.9K | — | View → |
| Feb 20, 2026 | Feb 24 9:05 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 60,000 | $30.10 | $1.8M | 432,886(D) | View → |
| Feb 20, 2026 | Feb 20 9:49 PM | Dube Eric M | Proposed Sale | 60,000 | $30.10 | $1.8M | — | View → |
| Feb 17, 2026 | Feb 19 9:10 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 10,000 | $27.83 | $278.3K | 105,211(D) | View → |
| Feb 17, 2026 | Feb 17 9:30 PM | ELIZABETH REED | Proposed Sale | 10,000 | $27.83 | $278.3K | — | View → |
| Feb 4, 2026 | Feb 5 9:05 PM | Jula InrigCHIEF MEDICAL OFFICER | Sale | 1,779 | $32.21 | $57.3K | 105,706(D) | View → |
| Feb 4, 2026 | Feb 5 9:05 PM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Sale | 1,745 | $32.19 | $56.2K | 111,226(D) | View → |
| Feb 4, 2026 | Feb 5 9:05 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 2,994 | $32.18 | $96.4K | 105,211(D) | View → |
| Feb 4, 2026 | Feb 4 9:07 PM | ELIZABETH REED | Proposed Sale | 2,994 | $32.18 | $96.4K | — | View → |
| Feb 4, 2026 | Feb 4 9:06 PM | JULA INRIG | Proposed Sale | 1,779 | $32.21 | $57.3K | — | View → |
| Feb 4, 2026 | Feb 4 9:01 PM | CHRISTOPHER CLINE | Proposed Sale | 1,745 | $32.19 | $56.2K | — | View → |
| Feb 3, 2026 | Feb 4 11:00 AM | Peter Heerma | Proposed Sale | 7,310 | $32.12 | $234.8K | — | View → |
| Feb 3, 2026 | Feb 4 2:59 AM | Elizabeth E. Reed | Proposed Sale | 7,175 | $32.12 | $230.5K | — | View → |
| Feb 3, 2026 | Feb 4 2:58 AM | Sandra Calvin | Proposed Sale | 4,333 | $32.12 | $139.2K | — | View → |
| Feb 3, 2026 | Feb 4 2:45 AM | Christopher Cline | Proposed Sale | 7,242 | $32.12 | $232.6K | — | View → |
| Feb 3, 2026 | Feb 4 2:37 AM | Jula Inrig | Proposed Sale | 6,956 | $32.12 | $223.4K | — | View → |
| Feb 3, 2026 | Feb 4 2:30 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 100,087 | $32.28 | $3.2M | 432,886(D) | View → |
| Feb 3, 2026 | Feb 4 2:30 AM | Jula InrigCHIEF MEDICAL OFFICER | Sale | 6,956 | $32.12 | $223.4K | 107,485(D) | View → |
| Feb 3, 2026 | Feb 4 2:30 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Sale | 7,242 | $32.12 | $232.6K | 112,971(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Sep 18 1:35 AM | William E. RoteChief Research Officer | Option Exercise | 112,850 | $26.88 | 0(D) | View → |
| Sep 15, 2026 | Sep 18 1:35 AM | William E. RoteChief Research Officer | Option Exercise | 78,650 | $25.25 | 350(D) | View → |
| Sep 17, 2026 | Sep 18 1:35 AM | Peter HeermaEVP, CHIEF COMMERCIAL OFFICER | Option Exercise | 8,282 | $22.40 | 44,837(D) | View → |
| Sep 16, 2026 | Sep 18 1:35 AM | Peter HeermaEVP, CHIEF COMMERCIAL OFFICER | Option Exercise | 172,717 | $26.88 | 500(D) | View → |
| Sep 15, 2026 | Sep 18 1:35 AM | Peter HeermaEVP, CHIEF COMMERCIAL OFFICER | Option Exercise | 77,190 | $26.88 | 28,474(D) | View → |
| Sep 15, 2026 | Sep 18 1:33 AM | Jula InrigEVP, Head of R&D & CMO | Option Exercise | 32,395 | $8.93 | 43,605(D) | View → |
| Sep 15, 2026 | Sep 18 1:32 AM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 37,500 | $15.46 | 0(D) | View → |
| Sep 17, 2026 | Sep 18 1:31 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 108,493 | $23.34 | 0(D) | View → |
| Sep 16, 2026 | Sep 18 1:31 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 195,841 | $23.34 | 108,493(D) | View → |
| Sep 15, 2026 | Sep 18 1:31 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 95,666 | $23.34 | 304,334(D) | View → |
| Sep 15, 2026 | Sep 18 1:30 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Option Exercise | 20,000 | $17.44 | 0(D) | View → |
| Sep 15, 2026 | Sep 18 1:29 AM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Option Exercise | 5,375 | $27.50 | 17,875(D) | View → |
| Sep 10, 2026 | Sep 11 8:05 PM | Meckler Jeffrey ADirector | Option Exercise | 20,000 | $26.52 | 0(D) | View → |
| Aug 18, 2026 | Aug 19 8:05 PM | LYONS GARY ADirector | Option Exercise | 5,000 | $17.44 | 0(D) | View → |
| Aug 17, 2026 | Aug 19 8:05 PM | LYONS GARY ADirector | Option Exercise | 5,000 | $17.44 | 5,000(D) | View → |
| Jun 12, 2026 | Jun 16 8:46 PM | Timothy CoughlinDirector | Option Exercise | 10,000 | $26.52 | 0(D) | View → |
| Jun 12, 2026 | Jun 16 8:42 PM | Roy D. BaynesDirector | Option Exercise | 4,500 | $21.38 | 0(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Brinkley Ruth WilliamsDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Ron SquarerDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 9:00 PM | Sandra PooleDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
Page 1 of 4
Next →